Technology Assisted Stepped Collaborative Care Intervention

  • End date
    Jun 29, 2022
  • participants needed
  • sponsor
    University of Pittsburgh
Updated on 29 January 2021
maintenance haemodialysis


This study evaluates a collaborative care intervention in reducing depression, fatigue and pain symptoms and improving health related quality of life in hemodialysis patients. Half of participants will receive the collaborative care intervention, while the other half will receive technology delivered health education information.


End-stage renal disease patients on hemodialysis experience substantial symptom burden with fatigue, pain and depression among the most debilitating and existing as symptom clusters. These symptom clusters can exacerbate one another, and are independent and strong predictors of poor health-related quality of life in hemodialysis patients. This study will look at the effect of a 12 week stepped care intervention on changes in depression, pain or fatigue and health related quality of life.

Condition Chronic renal failure, Hemodialysis, Stage 5 Chronic Kidney Disease, Chronic Kidney Disease Stage 5, CKD Stage 5, end stage renal disease, chronic renal disease, end-stage renal disease, esrd, end-stage renal failure, end stage kidney disease, end stage renal failure
Treatment TASCCI, Technology Delivered Health Education Intervention
Clinical Study IdentifierNCT03440853
SponsorUniversity of Pittsburgh
Last Modified on29 January 2021


Yes No Not Sure

Inclusion Criteria

18 years or older
undergoing thrice-weekly maintenance hemodialysis for > 3 months
English speaking
able to provide informed consent
no evidence of thought disorder, delusions or active suicidal ideation

Exclusion Criteria

thought disorder, delusions or active suicidal ideation
active substance abuse
too ill or cognitively impaired to participate based on clinicians' judgment
anticipated life expectancy of less than 1 year
unable or unwilling to adhere to study protocol
participating in another clinical trial or taking an investigational drug
scheduled for living donor kidney transplant within next 6 months
relocating to another dialysis unit within 6 months
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note